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Although the function of astrocytic gap junctions under ischemia is still under debate, increased expression of connexin 43
(Cx43) has been observed in ischemic brain lesions, suggesting that astrocytic gap junctions could provide neuronal protection
against ischemic insult. Moreover, diﬀerent connexin subtypes may play diﬀerent roles in pathological conditions. We used
immunohistochemical analysis to investigate alterations in the expression of connexin subtypes in human stroke brains. Seven
samples, sectioned after brain embolic stroke, were used for the analysis. Data, evaluated semiquantitatively by computer-assisted
densitometry,wascomparedbetweentheintacthemisphereandischemiclesions.TheresultsshowedthatthecoexpressionofCx32
and Cx45 with neuronal markers was signiﬁcantly increased in ischemic lesions. Cx43 expression was signiﬁcantly increased in the
colocalization with astrocytes and relatively increased in the colocalization with neuronal marker in ischemic lesions. Therefore,
Cx32, Cx43, and Cx45 may respond diﬀerently to ischemic insult in terms of neuroprotection.
Copyright © 2009 Taizen Nakase et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Astrocytes are a major cell type in the central nervous system
and play an important role in regulating brain metabolism
[1, 2]. Moreover, astrocytes compose the frame network
and communicate through gap junctions. A gap junction
hemichannel consists of six connexins, and the connexin
43 (Cx43) is a main subtype of astrocytic gap junctions
[3, 4]. Previous studies showed that heterozygous Cx43 null
mice exhibited signiﬁcantly increased infarct volume [5]
and enhanced apoptosis following ischemic brain insult [6].
Likewise, mice lacking Cx43 in astrocytes showed a signiﬁ-
cantly increased infarct volume and ampliﬁed inﬂammatory
response in the penumbra compared to control littermates
[7]. These results suggested that astrocytic gap junctions
may play a critical role in controlling neuronal apopto-
sis and inﬂammatory response following brain ischemia.
Moreover, in ischemic brain lesions of human samples,
the expressed level of Cx43 was signiﬁcantly increased in
the penumbra compared to the intact area [8]. Therefore,
astrocytic gap junctions may provide neuronal protection
against ischemic insult not only in animal models but also
in the human brain. However, the eﬀects of astrocytic gap
junctions on pathological conditions are still being debated
[9, 10]. Recently, gap junctions composed of diﬀerent
types of connexins have been reported to have selective
permeability for diﬀerent biological molecules [11]. A few
reports have also reported alterations of connexin expression
under pathological conditions in the human brain [12,
13].
In this study, we used immunohistochemical analysis to
examinethelevelsofCx26,Cx32,Cx43,andCx45expression
in neurons and astrocytes in ischemic lesions from the view
point of human brain pathology.
2.MaterialsandMethods
2.1. Samples. We screened postmortem human brain sam-
ples with ischemic stroke (n = 53) in our hospital. First, we
carefullycheckedallclinicalrecordsandimageexaminations,
such as CT, MRI, MRA, and ultrasound echo cardiography2 Journal of Biomedicine and Biotechnology
Table 1: Background of all cases. F: female, M: male, lt.: left, rt.: right, MCA: middle cerebral artery, PCA: posterior cerebral artery, ACA:
anterior cerebral artery, ICA: internal carotid artery.
No. Age Sex Symptoms Lesions Duration to death
(1) 76 F sudden onset, lt. hemiparesis Rt. MCA & PCA territories 4 days, 3 hours
(2) 74 M sudden onset, lt. hemiparesis Rt. ACA & MCA territories 2 days, 5 hours
(3) 70 F sudden onset, lt. hemiparesis Rt. ICA territory 4 days, 3 hours
(4) 73 M sudden onset, lt. hemiparesis Rt. MCA territory 5 days, 18 hours
(5) 87 F sudden onset, rt. hemiparesis Lt. MCA territory 6 days, 5 hours
(6) 82 M sudden onset, rt. hemiparesis Lt. ACA & MCA territories 5 days, 12 hours
(7) 77 F sudden onset, rt. hemiparesis Lt. MCA territory 6 days
Ave. 77 ±5.8 4 days, 20 hours
of all sample cases. Embolic infarction brains sectioned after
stroke were recruited in this study. Because of restricting
artifacts in the pathological analysis, we selected only those
cases with atrial ﬁbrillation (Af) as the embolic source.
They were sectioned within one week after hospitalization.
Then, 7 cases were well preserved and ﬁt our criteria for
pathological observation. Precise clinical data are shown in
Table 1.
2.2. Immunohistochemistry. The samples were ﬁxed in phos-
phatebuﬀeredparaformaldehydeforonemonthandembed-
ded in paraﬃn blocks. We observed whole brain sections
with hematoxyline and eosin (H&E) staining under pho-
tomicroscope (Eclipse E800, Nikon, Tokyo, Japan). Then,
smaller brain samples (approximately 3cm × 2cm) were
sectioned from the intact and ischemic cortex and included
surrounding areas as shown in the representative picture
(Figure 1). These brain sections (5μm in thickness) were
mounted on glass slides and deparaﬃnized with xylene and
graded ethanol solutions. Sections were then immersed in
methanol with 0.3% H2O2 for 15 minutes to inactivate
internal peroxidase. After the slides were treated with 0.1%
trypsin for 5 minutes, they were irradiated with microwaves
in 0.01M citrate buﬀer (pH 6.0) for 5 minutes at 500W,
followed by 20 minutes cooling for antigen-retrieval. The
samples were then blocked with Protein Block Serum-Free
(X0909, Dako, Glostrup, Denmark) for 30 minutes at room
temperature.Thesectionswereincubatedwithglialﬁbrillary
acidic protein (GFAP: monoclonal, Dako), microtubule-
associatedprotein2(MAP2:monoclonal,Chemicon,Temec-
ula, CA), connexin 26 (Cx26: polyclonal, Chemicon), Cx32
(polyclonal, ProteinTech Group Inc., Chicago, IL), Cx43
(polyclonal, Chemicon), and Cx45 (polyclonal, Alpha diag-
nostic Intl., San Antonio, TX) antibodies (dilution was 1 :
500, 1 : 1000, 1 : 500, 1 : 200, 1 : 500, and 1 :
400, resp.) in 0.3% Tween20 in PBS overnight at 4◦C, then
reacted with appropriate secondary antibodies (Alexa Fluor,
Molecular Probes Inc., Eugene, OR) in 0.3% Tween20 in PBS
for 30 minutes at room temperature. As for the primary
antibodies, GFAP was used for the detection of astrocytes,
and MAP2 was used as the neuronal marker. The sections
were observed under a luminescence microscope (Nikon
Eclipse E600) and images captured with an attached digital
camera (DXM1200C, Nikon).
(a) (b)
Figure 1: Representative picture of brain slice stained with H&E.
Pale colored area shows the infarct lesion. Rectangle lined areas
indicate the selected regions of interest (ischemic cortex (a) and
intact cortex (b)).
2.3. Morphometry. Because we were not able to evaluate the
exact amount of protein in tissue which was used in this
study, we analyzed the amount of protein expression semi-
quantitatively. That is, the area of immunoreactive plaques
was measured in four randomly selected regions (220μm
× 165μm square) and comparisons made between intact
and ischemic peripheral areas. The analysis was performed
with the aid of computer software (Scion Image Beta 4.0.2,
Scion Image Co., Frederick, MD). Pixel counts were used
for calculation. All measurements were repeated on two
diﬀerent slides for each patient. On the pictures of double
immunohistochemical staining, yellow plaques represent
the coexpression of connexin proteins and neuronal or
astrocytic markers. These yellow plaques were extracted
with the assistance of computer software (Adobe Photoshop
CS2, Adobe Systems Inc., San Jose, CA), to assess the
amount of colocalized connexins. All acquired images were
standardized by subtracting background density; that is,
particles with sizes smaller than 50 pixels or larger than 500
pixels were excluded from images in our samples, as they are
staining debris conﬁrmed by negative controls.
2.4. Statistical Analysis. All data is presented as mean ± SD
values for each model. Mean values in each lesion were
compared by an ANOVA posthoc test, Bonferroni/Dunn
method using Stat View J 5.0 software (SAS Institute Inc.,
C a r y ,N C ) .V a l u e so fP<. 05 were considered as signiﬁcant.Journal of Biomedicine and Biotechnology 3
3. Results andDiscussion
We observed the expression of diﬀerent types of connexins
in neurons and astrocytes to assess whether connexins play
diﬀerent roles under ischemic conditions. In this study, the
expression of Cx26, Cx32, Cx43, and Cx45 was investigated
because of previous reports in which critical roles for these
connexins were suggested. Cx26 has been reported to form
am a j o rc o m p o n e n to fa s t r o c y t i cg a pj u n c t i o n s[ 14, 15],
although its presence and function in the brain is still under
debate [16, 17]. Hemichannels formed by Cx26 and Cx32
have been reported to pass cGMP more eﬀectively than Cx32
homomeric hemichannels, suggesting that the eﬀect of Cx26
isspeciﬁcincGMPtransport[18].Cx32isexpressednotonly
in gap junctions of Schwann cells [19] but also in neurons
and oligodendrocytes in the central nervous system (CNS)
[20, 21]. Cx32 was reported to participate in regulating
the permeability of adenosine, a critical component of ATP
[22]. Moreover, Cx32 knockout mice presented ampliﬁed
neuronal loss following brain ischemia as compared to wild
type mice [23]. Cx45 is reported to be expressed in neuronal
and oligodendrocytic gap junctions [24, 25]. Electrical
synapses composed of gap junctions, in which the main
subtype of connexin is Cx45 [26], could disrupt chemical
neurotransmission during development and regeneration
[27]. However, it has also been reported that a Ca2+ inﬂux
has a critical impact on spreading cell damage from the
core lesion to the penumbral area after ischemia [28, 29].
Therefore, the role of electrical synapses composed of gap
junctions against ischemic insult is still controversial. Cx43
is a major component of astrocytic gap junctions [3, 4].
We have reported that the reduction of Cx43 expression
extended neuronal apoptosis and ampliﬁed gliosis following
ischemia [7, 30]. Moreover, gap junctions composed of
Cx43 are reported to be involved in the distribution of ATP
between attached cells [22].
The immunohistochemical staining revealed that the
gross expression of Cx32 (Figures 2(a) and 2(b))w a s
relatively increased in the ischemic area compared to the
intact area (Figure 2(g): P = .051). As seen in Figures 2(c)
and 2(d), the expression of the yellow plaques representing
Cx32 showed colocalization with MAP2. Expression was
visualized along neuronal axons and was more abundant in
the ischemic lesion than those in the intact area. Accord-
ing to calculations of the amount of the yellow plaques,
Cx32 expression in MAP2 positive areas was signiﬁcantly
increased in the ischemic lesion compared to the intact area
(Figure 2(g), P = .009). On the contrary, the expression of
Cx32 on GFAP positive cells was not changed in the ischemic
lesion (Figures 2(e), 2(f),a n d2(g)).
The expression of Cx45 (Figures 3(a) and 3(b))w a s
signiﬁcantlyincreasedinischemiclesionscomparedtointact
area (Figure 3(g), P = .0003). Cx45 expression colocalized
in MAP2 positive area was observed in neuronal body
and axons (Figures 3(c) and 3(d)) and was signiﬁcantly
increased in the ischemic lesion compared to the intact area
(Figure 3(g), P = .0047). As shown in Figures 3(e) and
3(f), the expression of Cx45 in GFAP positive cells was not
changed between ischemic and intact regions (Figure 3(g)).
As shown in Figures 4(a) and 4(b), the gross expression
of Cx43 was signiﬁcantly increased in ischemic lesions
compared to intact tissue (Figure 4(g), P = .0154). The
coexpression of Cx43 and MAP2 (Figures 4(c) and 4(d))
was visualized as punctate staining and relatively increased
in the ischemic lesion compared to intact area (Figure 4(g),
P = .0599). The coexpression of Cx43 and GFAP (Fig-
ures 4(e) and 4(f)) was signiﬁcantly increased in ischemic
lesions compared to intact area (Figure 4(g), P<. 001).
The results supported previous reports in which showed
increased Cx43 expression in the ischemic lesion [8, 31,
32].
Meanwhile, the gross expression of Cx26 was not
changed between the intact area and ischemic lesion. The
amount of Cx26 expression which colocalized with MAP2 or
GFAPpositivearearevealednosigniﬁcantdiﬀerencebetween
intact and ischemic regions (Figure 5). Since the role of Cx26
in astrocytic gap junctions is still controversial, our ﬁndings
may support previous reports [17].
In the ischemic lesion, neurons and astrocytes are
perishing, and their cell bodies and processes will shrink.
On the other hand, some astrocytes and microglia react
by expanding their body and processes as an inﬂammatory
response. As mentioned above, both Cx32 and Cx45 exist
in neurons and/or oligodendrocytes, and Cx43 exists in
astrocytes. In this study, a signiﬁcant increase of Cx32 and
Cx45 expression was mostly observed in neuronal axons in
ischemic lesions. In the CNS, the neuronal axon is covered
with a myelin sheath of oligodendrocytes, and therefore, the
expression of Cx32 and Cx45 could be increased in either,
or both, neuronal axons and oligodendrocytes after ischemic
insult. The Cx43 expression was signiﬁcantly increased in
astrocytes within ischemic lesions and was slightly increased
in the coexpression of Cx43 and MAP2 after ischemic insult,
suggesting that Cx43 may participate in the composition of
gap junctions between neurons and astrocytes activated by
ischemic stress. Since Cx32 relates to adenosine transport
and Cx43 participates in distributing ATP, both Cx32 and
Cx43 may play an important role in maintaining energy
support after ischemic insult. Cx45 has been reported to play
a role in spreading chemical stress against neurons from the
ischemic core to peripheral area. It would require further
assessment to reveal the eﬀect of increased Cx45 expression
following ischemia.
We could not assess the expression of Cx36, one of
the major components of neuronal gap junctions, because
our samples, ﬁxed in paraformaldehyde and embedded in
paraﬃn blocks, were unable to be stained with any anti-
Cx36 antibodies we had available. Cx30 is also a major
connexin subtype in astrocytic gap junctions. However,
the anti-Cx30 antibodies which were used in this study
did not show reactivity against human brain samples.
Since the evidence showing that Cx30 may compensate
for the lack of Cx43 has been accumulating [6, 17], the
alteration of Cx30 expression after ischemic stress should
be explored. Moreover, we had not directly observed gap
junctions between neurons and astrocytes. Alternatively,
double immunohistochemical staining was used for investi-
gating the expression of speciﬁc connexins in neurons and4 Journal of Biomedicine and Biotechnology
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Figure 2: Cx32 immunoﬂuorescent stainings indicate ampliﬁed expression in the ischemic lesion (b) compared to the intact area
(a). Inset pictures of (c) and (d) represent double immunoﬂuorescent staining with Cx32 (green) and MAP2 (red). Representative
pictures in second row show the extracted area as yellow region of the double immunoﬂuorescent staining from intact (c) and
ischemic area (d). The yellow region which stands for Cx32 immunopositive area colocalized with MAP2 shows increased expression
in the ischemic periphery. Inset pictures of (e) and (f) represent double immunoﬂuorescent staining with Cx32 (green) and GFAP
(red). Representative pictures in third row show the extracted area as yellow region of the double immunoﬂuorescent staining from
intact (e) and ischemic area (f). The yellow region which stands for Cx32 immunopositive area colocalized with GFAP seems
similar level of the expression between normal and ischemic area. Black bars in graph (g) indicate the average counts of protein
expressions. The Cx32 expression was relatively increased in the ischemic area compared to the intact area (†: P = .0510). The
coexpression of Cx32 and MAP2 was signiﬁcantly increased in the ischemic lesion as compared to the intact area (∗∗: P<. 01).
However, there was no statistical diﬀerence in Cx32 and GFAP coexpression between intact and ischemic areas. Scale bar indicates
50μm.Journal of Biomedicine and Biotechnology 5
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Figure 3: Cx45 immunoﬂuorescent stainings indicate ampliﬁed expression in the ischemic lesion (b) compared to the intact area (a). Inset
pictures of (c) and (d) represent double immunoﬂuorescent staining with Cx45 (green) and MAP2 (red). Representative pictures in second
row show the extracted area as yellow region of the double immunoﬂuorescent staining from intact (c) and ischemic area (d). The yellow
region which stands for Cx45 immunopositive area colocalized with MAP2 shows increased expression in the ischemic periphery. Inset
pictures of (e) and (f) represent double immunoﬂuorescent staining with Cx45 (green) and GFAP (red). Representative pictures in third row
show the extracted area as yellow region of the double immunoﬂuorescent staining from intact (e) and ischemic area (f). The yellow region
which stands for Cx45 immunopositive area colocalized with GFAP shows no diﬀerence of expression between intact and ischemic area.
Black bars in graph (g) indicate the average counts of protein expressions. The Cx45 expression was signiﬁcantly increased in the ischemic
area compared to the intact area. The coexpression of Cx45 and MAP2 was signiﬁcantly increased in the ischemic lesion as compared to the
intact area. However, no statistical alteration was observed in the amount of coexpression of Cx45 and GFAP between intact and ischemic
regions. Scale bar indicates 50μm. ∗∗: P<. 01.6 Journal of Biomedicine and Biotechnology
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Figure 4: Cx43 immunoﬂuorescent stainings indicate ampliﬁed expression in the ischemic lesion (b) compared to the intact area (a).
Inset pictures of (c) and (d) represent double immunoﬂuorescent staining with Cx43 (green) and MAP2 (red). Representative pictures in
second row show the extracted area as yellow region of the double immunoﬂuorescent staining from intact (c) and ischemic area (d). The
yellow region which stands for Cx43 immunopositive area colocalized with MAP2 shows ampliﬁed expression in the ischemic periphery.
Inset pictures of (e) and (f) represent double immunoﬂuorescent staining with Cx43 (green) and GFAP (red). Representative pictures in
third row show the extracted area as yellow region of the double immunoﬂuorescent staining from intact (e) and ischemic area (f). The
yellow region which stands for Cx43 immunopositive area colocalized with GFAP also shows increased expression level in ischemic lesion
as compared to intact area. Black bars in graph (g) indicate the average counts of protein expressions. The Cx43 expression alone and the
amountofcoexpressionwithCx43orGFAPweresigniﬁcantlyincreasedintheischemiclesioncomparedtotheintactarea.Thecoexpression
of Cx43 and MAP2 was increased in ischemic lesion compared to intact area (†: P = .0599). Scale bar indicates 50μm. ∗∗: P<. 01, ∗:
P<. 05.Journal of Biomedicine and Biotechnology 7
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Figure 5: Cx26 immunoﬂuorescent stainings show similar ﬁnding between intact area (a) and ischemic lesion (b). Inset pictures represent
double immunoﬂuorescent staining with Cx26 (green) and MAP2 (red) in (c) and (d) and with Cx26 (green) and GFAP (red) in (e) and
(f). Representative pictures in second row show the extracted area as yellow region of the double immunoﬂuorescent staining from intact
(c) and ischemic area (d). The yellow region which stands for Cx26 immunopositive area colocalized with MAP2 shows the same amount of
expression. The yellow region which stands for Cx26 immunopositive area colocalized with GFAP shows no diﬀerence of expression between
intact and ischemic area. Black bars in graph (g) indicate the average counts of protein expressions. The Cx26 expression was not changed in
the ischemic lesion as compared to the intact area. No statistical alteration was observed in the amount of coexpression of Cx26 and MAP2
nor Cx26 and GFAP between intact and ischemic regions. Scale bar indicates 50μm.
astrocytes. In the future, gap junctions between diﬀerent
cell types should be directly observed through an electron
microscope. Gap junctions of oligodendrocytes or microglia
need further investigation in order to conﬁrm the role of gap
junctional intercellular communication following ischemic
insult.
In conclusion, this is the ﬁrst report that has revealed
ampliﬁed expressions of Cx32 and Cx45 in MAP2 positive
areas within the ischemic lesion from the view point of
human brain pathology. Furthermore, Cx32 and Cx43 may
have a neuroprotective role under ischemic conditions in the
human brain.8 Journal of Biomedicine and Biotechnology
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